BIOMAT Database Logo BIOMAT Database Logo

Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography. 1991

L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Dementia Research Clinic, School of Medicine, Johns Hopkins University, Baltimore, MD 21205.

The effect of acute, intravenous administration of physostigmine on measures of brain activity and cognitive functioning were investigated in 14 patients with Alzheimer's disease. Regional cerebral glucose metabolism was assessed using (18F)-fluoro-2-deoxy-D-glucose and positron emission tomography, and cerebral blood flow was assessed using 123I-iodoamphetamine single photon emission tomography. Although physostigmine enhanced cerebral blood flow in most patients, only one patient showed significant clinical improvement. This patient, however, also showed a very pronounced improvement in cerebral glucose metabolism. It is concluded that these preliminary findings hold considerable promise for our appreciation of the pathophysiology of dementing illness as well as our understanding of centrally acting compounds of interest in Alzheimer's disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010830 Physostigmine A cholinesterase inhibitor that is rapidly absorbed through membranes. It can be applied topically to the conjunctiva. It also can cross the blood-brain barrier and is used when central nervous system effects are desired, as in the treatment of severe anticholinergic toxicity. Eserine
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002560 Cerebrovascular Circulation The circulation of blood through the BLOOD VESSELS of the BRAIN. Brain Blood Flow,Regional Cerebral Blood Flow,Cerebral Blood Flow,Cerebral Circulation,Cerebral Perfusion Pressure,Circulation, Cerebrovascular,Blood Flow, Brain,Blood Flow, Cerebral,Brain Blood Flows,Cerebral Blood Flows,Cerebral Circulations,Cerebral Perfusion Pressures,Circulation, Cerebral,Flow, Brain Blood,Flow, Cerebral Blood,Perfusion Pressure, Cerebral,Pressure, Cerebral Perfusion
D003847 Deoxyglucose 2-Deoxy-D-arabino-hexose. An antimetabolite of glucose with antiviral activity. 2-Deoxy-D-glucose,2-Deoxyglucose,2-Desoxy-D-glucose,2 Deoxy D glucose,2 Deoxyglucose,2 Desoxy D glucose
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response

Related Publications

L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Quantitative positron emission tomography and single photon emission computed tomography measurements of human cerebral blood flow.
January 1987, American journal of physiologic imaging,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Longitudinal study of cerebral blood flow in Alzheimer's disease using single photon emission tomography.
February 1997, Psychiatry research,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study.
August 2001, The Journal of clinical endocrinology and metabolism,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography.
August 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Regional cerebral blood flow determined with single photon emission computed tomography and positron emission tomography. A comparative study.
January 1986, Acta radiologica. Supplementum,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography.
June 1985, Lancet (London, England),
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Cerebral blood flow tomography by single photon emission computerized tomography using 133Xe in cerebrovascular disease.
January 1986, Monographs on atherosclerosis,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
January 1989, Radiation medicine,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Regional cerebral blood flow in cerebrovascular disease by SPECT (single photon emission computerized tomography).
January 1983, Journal of neuroradiology = Journal de neuroradiologie,
L Tune, and J Brandt, and J J Frost, and G Harris, and H Mayberg, and C Steele, and A Burns, and J Sapp, and M F Folstein, and H N Wagner
Cerebral blood flow determinations by positron emission tomography.
January 1982, Journal of neurosurgical sciences,
Copied contents to your clipboard!